BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 35937834)

  • 1. Plasma Apolipoproteins Predicting the Occurrence and Severity of Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus.
    Zhang X; Nie Y; Gong Z; Zhu M; Qiu B; Wang Q
    Front Endocrinol (Lausanne); 2022; 13():915575. PubMed ID: 35937834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating level of homocysteine contributes to diabetic retinopathy associated with dysregulated lipid profile and impaired kidney function in patients with type 2 diabetes mellitus.
    Chen X; Zhang X; Nie Y; Gong Z; Sivaprasad S; Fung AT; Wang Q; Qiu B; Xie R; Wang Y
    Eye (Lond); 2023 May; 37(7):1383-1389. PubMed ID: 35739242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The link between diabetic retinal and renal microvasculopathy is associated with dyslipidemia and upregulated circulating level of cytokines.
    Chen X; Zhang X; Gong Z; Yang Y; Zhang X; Wang Q; Wang Y; Xie R
    Front Public Health; 2022; 10():1040319. PubMed ID: 36733289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulated Serum Lipid Metabolism Promotes the Occurrence and Development of Diabetic Retinopathy Associated With Upregulated Circulating Levels of VEGF-A, VEGF-D, and PlGF.
    Zhang X; Qiu B; Wang Q; Sivaprasad S; Wang Y; Zhao L; Xie R; Li L; Kang W
    Front Med (Lausanne); 2021; 8():779413. PubMed ID: 34904074
    [No Abstract]   [Full Text] [Related]  

  • 5. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
    Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The abnormal changes of apolipoprotein(s) in patients with type 2 diabetes mellitus].
    Ren Y; Tian H; Liu B; Liang J; Zhang X; Yao J; Xu Y
    Hua Xi Yi Ke Da Xue Xue Bao; 2001 Mar; 32(1):48-51, 69. PubMed ID: 12733353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enrichment of Triglyceride-Rich Lipoproteins with Apolipoprotein C-I Is Positively Associated with Their Delayed Plasma Clearance Independently of Other Transferable Apolipoproteins in Postmenopausal Overweight and Obese Women.
    Wassef H; Bissonnette S; Dufour R; Davignon J; Faraj M
    J Nutr; 2017 May; 147(5):754-762. PubMed ID: 28356429
    [No Abstract]   [Full Text] [Related]  

  • 8. Apolipoproteins C-III and E in apoB- and non-apoB-containing lipoproteins in two populations at contrasting risk for myocardial infarction: the ECTIM study. Etude Cas Témoins sur 'Infarctus du Myocarde.
    Luc G; Fievet C; Arveiler D; Evans AE; Bard JM; Cambien F; Fruchart JC; Ducimetiere P
    J Lipid Res; 1996 Mar; 37(3):508-17. PubMed ID: 8728314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma turnover of HDL apoC-I, apoC-III, and apoE in humans: in vivo evidence for a link between HDL apoC-III and apoA-I metabolism.
    Cohn JS; Batal R; Tremblay M; Jacques H; Veilleux L; Rodriguez C; Mamer O; Davignon J
    J Lipid Res; 2003 Oct; 44(10):1976-83. PubMed ID: 12867543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of the apolipoprotein C-III 3238C>G polymorphism and alcohol consumption on serum triglyceride levels.
    Ruixing Y; Yiyang L; Meng L; Kela L; Xingjiang L; Lin Z; Wanying L; Jinzhen W; Dezhai Y; Weixiong L
    Lipids Health Dis; 2010 Aug; 9():86. PubMed ID: 20716347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low serum apolipoprotein A1/B ratio is associated with proliferative diabetic retinopathy in type 2 diabetes.
    Hu A; Luo Y; Li T; Guo X; Ding X; Zhu X; Wang X; Tang S
    Graefes Arch Clin Exp Ophthalmol; 2012 Jul; 250(7):957-62. PubMed ID: 22327732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of corpulence parameters and haemoglobin A1c on metabolic control in type 2 diabetic patients: comparison of apolipoprotein B/A-I ratio with fasting and postprandial conventional lipid ratios.
    Diaf M; Khaled BM; Sellam F
    Libyan J Med; 2015; 10(1):27400. PubMed ID: 25959906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of simvastatin on plasma lipids and apolipoproteins in familial hypercholesterolemic swine.
    Hasler-Rapacz J; Kempen HJ; Princen HM; Kudchodkar BJ; Lacko A; Rapacz J
    Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):137-43. PubMed ID: 8548414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The compositional abnormalities of lipoproteins in diabetic renal failure.
    Attman PO; Knight-Gibson C; Tavella M; Samuelsson O; Alaupovic P
    Nephrol Dial Transplant; 1998 Nov; 13(11):2833-41. PubMed ID: 9829487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma apolipoprotein concentrations in familial apolipoprotein A-I and A-II deficiency (Tangier disease).
    Alaupovic P; Schaefer EJ; McConathy WJ; Fesmire JD; Brewer HB
    Metabolism; 1981 Aug; 30(8):805-9. PubMed ID: 6790903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein(a) and Apolipoproteins as Predictors for Diabetic Retinopathy and Its Severity in Adults With Type 2 Diabetes: A Case-Cohort Study.
    Moosaie F; Davatgari RM; Firouzabadi FD; Esteghamati S; Deravi N; Meysamie A; Khaloo P; Nakhjavani M; Esteghamati A
    Can J Diabetes; 2020 Jul; 44(5):414-421. PubMed ID: 32205075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol pathway biomarkers are associated with neuropsychological measures in multiple sclerosis.
    Siddiqui K; Browne RW; Benedict RHB; Jakimovski D; Weinstock-Guttman B; Zivadinov R; Ramanathan M
    Mult Scler Relat Disord; 2023 Jan; 69():104374. PubMed ID: 36403378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atorvastatin decreases apolipoprotein C-III in apolipoprotein B-containing lipoprotein and HDL in type 2 diabetes: a potential mechanism to lower plasma triglycerides.
    Dallinga-Thie GM; Berk-Planken II; Bootsma AH; Jansen H;
    Diabetes Care; 2004 Jun; 27(6):1358-64. PubMed ID: 15161788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Very-Low-Density Lipoprotein-Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III.
    Pechlaner R; Tsimikas S; Yin X; Willeit P; Baig F; Santer P; Oberhollenzer F; Egger G; Witztum JL; Alexander VJ; Willeit J; Kiechl S; Mayr M
    J Am Coll Cardiol; 2017 Feb; 69(7):789-800. PubMed ID: 28209220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation analysis of lipids and apolipoproteins in plasma HDL, LDL and VLDL of normal subjects and endogenous hypertriglyceridemics].
    Fan P; Liu B
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Jun; 26(2):141-5. PubMed ID: 7490018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.